Profil
Dan Parry is currently the Chief Financial Officer at Hydrexia Pty Ltd. Prior to this, he was the Chief Financial & Operating Officer at Oventus Medical Ltd. from 2017 to 2021.
Before that, he worked as the Chief Financial Officer & Secretary at Implicit Bioscience Ltd. from 2005 to 2013.
Mr. Parry holds an MBA from Kellogg School of Management.
Aktiva positioner av Dan Parry
| Företag | Position | Start |
|---|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Finansdirektör/CFO | 2013-09-01 |
Tidigare kända positioner av Dan Parry
| Företag | Position | Slut |
|---|---|---|
| OVES MEDI | Finansdirektör/CFO | 2021-06-04 |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Finansdirektör/CFO | 2013-01-01 |
Dan Parrys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Technology Services |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oventus Medical Ltd.
Oventus Medical Ltd. Medical SpecialtiesHealth Technology Develops oral appliances for the treatment of obstructive sleep disordered and snoring | Health Technology |
















